190 related articles for article (PubMed ID: 12162793)
1. 24-hour efficacy of once-daily desloratadine therapy in patients with seasonal allergic rhinitis [ISRCTN32042139].
Salmun LM; Lorber R
BMC Fam Pract; 2002 Aug; 3():14. PubMed ID: 12162793
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of desloratadine 5 mg in asthma patients with seasonal allergic rhinitis and nasal congestion.
Berger WE; Schenkel EJ; Mansfield LE;
Ann Allergy Asthma Immunol; 2002 Nov; 89(5):485-91. PubMed ID: 12452207
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of an extended-release formulation of desloratadine and pseudoephedrine vs the individual components in the treatment of seasonal allergic rhinitis.
Pleskow W; Grubbe R; Weiss S; Lutsky B
Ann Allergy Asthma Immunol; 2005 Mar; 94(3):348-54. PubMed ID: 15801245
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of desloratadine, 5 mg, compared with fexofenadine, 180 mg, in patients with symptomatic seasonal allergic rhinitis.
Berger WE; Lumry WR; Meltzer EO; Pearlman DS
Allergy Asthma Proc; 2006; 27(3):214-23. PubMed ID: 16913264
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of desloratadine/pseudoephedrine combination vs its components in seasonal allergic rhinitis.
Grubbe RE; Lumry WR; Anolik R
J Investig Allergol Clin Immunol; 2009; 19(2):117-24. PubMed ID: 19476015
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of desloratadine/pseudoephedrine tablet, 2.5/120 mg two times a day, versus individual components in the treatment of patients with seasonal allergic rhinitis.
Chervinsky P; Nayak A; Rooklin A; Danzig M
Allergy Asthma Proc; 2005; 26(5):391-6. PubMed ID: 16450574
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of diphenhydramine vs desloratadine and placebo in patients with moderate-to-severe seasonal allergic rhinitis.
Raphael GD; Angello JT; Wu MM; Druce HM
Ann Allergy Asthma Immunol; 2006 Apr; 96(4):606-14. PubMed ID: 16680933
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the effects of desloratadine 5-mg daily and placebo on nasal airflow and seasonal allergic rhinitis symptoms induced by grass pollen exposure.
Horak F; Stübner P; Zieglmeyer R; Harris AG
Allergy; 2003 Jun; 58(6):481-5. PubMed ID: 12757447
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of desloratadine 5 mg once daily in patients with symptoms of seasonal allergic rhinitis: results of a Canadian multicenter, open-label trial.
Keith PK; Luciuk G
Clin Ther; 2007 Mar; 29(3):419-26. PubMed ID: 17577463
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of desloratadine in the treatment of perennial allergic rhinitis.
Simons FE; Prenner BM; Finn A;
J Allergy Clin Immunol; 2003 Mar; 111(3):617-22. PubMed ID: 12642846
[TBL] [Abstract][Full Text] [Related]
11. Comparative effects of desloratadine versus montelukast on asthma symptoms and use of beta 2-agonists in patients with seasonal allergic rhinitis and asthma.
Baena-Cagnani CE; Berger WE; DuBuske LM; Gurné SE; Stryszak P; Lorber R; Danzig M
Int Arch Allergy Immunol; 2003 Apr; 130(4):307-13. PubMed ID: 12740532
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of desloratadine on conjunctival allergen challenge-induced ocular symptoms.
Torkildsen GL; Gomes P; Welch D; Gopalan G; Srinivasan S
Clin Exp Allergy; 2009 Jul; 39(7):1052-9. PubMed ID: 19302250
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the efficacy and safety of bilastine 20 mg vs desloratadine 5 mg in seasonal allergic rhinitis patients.
Bachert C; Kuna P; Sanquer F; Ivan P; Dimitrov V; Gorina MM; van de Heyning P; Loureiro A;
Allergy; 2009 Jan; 64(1):158-65. PubMed ID: 19132976
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of azelastine nasal spray in patients with an unsatisfactory response to loratadine.
Berger WE; White MV;
Ann Allergy Asthma Immunol; 2003 Aug; 91(2):205-11. PubMed ID: 12952117
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of desloratadine in intermittent allergic rhinitis: a GA(2)LEN study.
Bousquet J; Bachert C; Canonica GW; Mullol J; Van Cauwenberge P; Bindslev Jensen C; Fokkens WJ; Ring J; Keith P; Lorber R; Zuberbier T;
Allergy; 2009 Oct; 64(10):1516-1523. PubMed ID: 19624554
[TBL] [Abstract][Full Text] [Related]
16. Desloratadine for the treatment of cypress pollen-induced allergic rhinitis.
Demoly P; Dreyfus I; Dhivert-Donnadieu H; Mesbah K
Ann Allergy Asthma Immunol; 2009 Sep; 103(3):260-6. PubMed ID: 19788025
[TBL] [Abstract][Full Text] [Related]
17. Desloratadine treatment for intermittent and persistent allergic rhinitis: a review.
Bachert C; van Cauwenberge P
Clin Ther; 2007 Sep; 29(9):1795-802. PubMed ID: 18035184
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of desloratadine in persistent allergic rhinitis - a GA²LEN study.
Bousquet J; Bachert C; Canonica GW; Mullol J; Van Cauwenberge P; Jensen CB; Fokkens WJ; Ring J; Keith P; Gopalan G; Lorber R; Zuberbier T;
Int Arch Allergy Immunol; 2010; 153(4):395-402. PubMed ID: 20559006
[TBL] [Abstract][Full Text] [Related]
19. Desloratadine therapy for symptoms associated with perennial allergic rhinitis.
Kim K; Sussman G; Hébert J; Lumry W; Lutsky B; Gates D
Ann Allergy Asthma Immunol; 2006 Mar; 96(3):460-5. PubMed ID: 16597081
[TBL] [Abstract][Full Text] [Related]
20. Desloratadine improves quality of life and symptom severity in patients with allergic rhinitis.
Pradalier A; Neukirch C; Dreyfus I; Devillier P
Allergy; 2007 Nov; 62(11):1331-4. PubMed ID: 17521311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
